Science & Enterprise subscription

Please share Science & Enterprise

RSS
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Computer-Aided Bone Graft Process Devised with Stem Cells

Leg in cast

A tissue engineering team developed a process that includes computer-assisted design for personalized grafts derived from a patient’s own stem cells, to repair bone defects caused by trauma or disease. . . . → Read More: Computer-Aided Bone Graft Process Devised with Stem Cells

More Damage Detected from Crispr-Cas9 Edits

Crispr genome edits illustration

A genetics lab in the U.K. revealed that a leading technique for editing genomes produces more unwanted damage to the edited genomes than previously understood. . . . → Read More: More Damage Detected from Crispr-Cas9 Edits

Exosome Technology Acquired for TBI, Stroke Therapies

Stroke circulation

A company developing therapies for brain injuries and neurodegenerative disorders is acquiring the rights to a process that treats these conditions with pieces of RNA transferred in tiny containers call exosomes. . . . → Read More: Exosome Technology Acquired for TBI, Stroke Therapies

RNA Nanoparticles Designed for Brain Cancer Therapy

Brain cell networks

Medical researchers and material scientists devised a technique for delivering tiny particles of genetic material to the brain, which help lab mice shrink or remove their brain tumors and survive longer. . . . → Read More: RNA Nanoparticles Designed for Brain Cancer Therapy

Stem Cell Transplants Found Safe for Spinal Cord Injuries

Spine model

Results from a clinical trial testing transplants of neural stem cells for spinal cord injuries show the therapies are safe for patients, with signs of improvement in most participants 1 to 2 years after treatment. . . . → Read More: Stem Cell Transplants Found Safe for Spinal Cord Injuries

FDA Delays Crispr Trial for Inherited Blood Diseases

Crispr-Cas9 illustration

The U.S. Food and Drug Administration put a hold on beginning a clinical trial of the emerging genome editing technique known as Crispr to treat inherited blood disorders. . . . → Read More: FDA Delays Crispr Trial for Inherited Blood Diseases

Clinical Trials Okayed for Sickle Cell Gene Editing

Sickle cell illustration

Two companies developing therapies for inherited blood disorders say the Food and Drug Administration approved their application to begin clinical trials of treatments for sickle cell disease with gene editing. . . . → Read More: Clinical Trials Okayed for Sickle Cell Gene Editing

Computer-Designed Heart Valves Operate Over Long Term

Engineered heart valve

A European research team designed customized heart valves with computer models, which when tested in sheep continued to perform in most cases for a year following implantation. . . . → Read More: Computer-Designed Heart Valves Operate Over Long Term

Crowdfunding Found Supporting Dubious Stem Cell Clinics

Crowdfunding graphic

More people now use crowdfunding campaigns to raise money to cover families’ medical costs, but the technique is also used to support treatments from stem cell clinics that exaggerate their outcomes and minimize their risks. . . . → Read More: Crowdfunding Found Supporting Dubious Stem Cell Clinics

Stem Cell Eye Implants Safe, Stop Visual Function Loss

Early results from a clinical trial show implants of replacement retina cells grown from stem cells are safe for people with a form of age-related macular degeneration, and at least stop the loss of visual function. . . . → Read More: Stem Cell Eye Implants Safe, Stop Visual Function Loss